There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

Cruises are a great way for travelers with COPD to see the world. Most large cruise lines allow passengers to travel with ...

For people with chronic obstructive pulmonary disease (COPD), breathing is often front of mind because it can be difficult, and it gets worse over time. There is no cure yet for COPD, but experts ...

The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM: US, France, Germany, Italy, Spain, ...

Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

The early use of interdisciplinary care services and special end-of-life units can improve the quality of end-of-life care for end-stage COPD patients and their families. Several features of COPD ...

Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.

Both companies are pursuing the COPD label for their respective biologics with ongoing late-stage studies ... The approval of Dupixent, an interleukin-4 receptor alpha antagonist that inhibits ...

The European Commission has become the first regulator worldwide to approve Sanofi and Regeneron’s IL-4 and IL-13 inhibitor ... showed signs of efficacy in COPD in a mid-stage trial that also ...

Full session details can be accessed on the ACAAI website. The poster will be available on the publications page of the Apogee website on October 24.